Review
doi: 10.1128/AAC.00749-08.
Epub 2008 Dec 15.
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development
Affiliations
- PMID: 19075046
- PMCID: PMC2650526
- DOI: 10.1128/AAC.00749-08
Item in Clipboard
Review
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development
Antimicrob Agents Chemother.
2009 Mar.
No abstract available
Similar articles
-
[New antitubercular drugs].Pneumonol Pol. 1990 Apr-May;58(4-5):163-6. Pneumonol Pol. 1990. PMID: 2168041 Polish. No abstract available.
-
Medicine. New TB drug promises shorter, simpler treatment.Science. 2004 Dec 10;306(5703):1872. doi: 10.1126/science.306.5703.1872. Science. 2004. PMID: 15591168 No abstract available.
-
Shortening the treatment of tuberculosis.Nat Biotechnol. 2005 Feb;23(2):187-8. doi: 10.1038/nbt0205-187. Nat Biotechnol. 2005. PMID: 15696148 No abstract available.
-
Prospects for development of new antimycobacterial drugs.J Infect Chemother. 2000 Mar;6(1):8-20. doi: 10.1007/s101560050043. J Infect Chemother. 2000. PMID: 11810525 Review.
-
Prospects for new antitubercular drugs.Curr Opin Microbiol. 2004 Oct;7(5):460-5. doi: 10.1016/j.mib.2004.08.011. Curr Opin Microbiol. 2004. PMID: 15451500 Review.
Cited by
-
Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.Diagn Microbiol Infect Dis. 2016 Jun;85(2):177-81. doi: 10.1016/j.diagmicrobio.2016.01.019. Epub 2016 Feb 3. Diagn Microbiol Infect Dis. 2016. PMID: 27036978 Free PMC article.
-
Oral Manifestations of Tuberculosis: Step towards Early Diagnosis.J Clin Diagn Res. 2014 Dec;8(12):ZE18-21. doi: 10.7860/JCDR/2014/10080.5281. Epub 2014 Dec 5. J Clin Diagn Res. 2014. PMID: 25654056 Free PMC article. Review.
-
Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.Antimicrob Agents Chemother. 2012 Apr;56(4):1735-43. doi: 10.1128/AAC.05742-11. Epub 2012 Jan 30. Antimicrob Agents Chemother. 2012. PMID: 22290959 Free PMC article.
-
Tuberculosis in the 21st century.Clin Med (Lond). 2011 Aug;11(4):353-7. doi: 10.7861/clinmedicine.11-4-353. Clin Med (Lond). 2011. PMID: 21853832 Free PMC article. No abstract available.
-
Comparative study on the bioavailability and bioequivalence of rifapentine capsules in humans.Front Pharmacol. 2025 Jan 17;15:1463575. doi: 10.3389/fphar.2024.1463575. eCollection 2024. Front Pharmacol. 2025. PMID: 39898756 Free PMC article.
References
-
- Acocella, G. 1978. Clinical pharmacokinetics of rifampicin. Clin. Pharmacokinet. 3:108-127. - PubMed
-
- Alangaden, G. J., and S. A. Lerner. 1997. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin. Infect. Dis. 25:1213-1221. - PubMed
-
- Andries, K., P. Verhasselt, J. Guillemont, H. W. Gohlmann, J. M. Neefs, H. Winkler, G. J. Van, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, E. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V. Jarlier. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223-227. - PubMed
-
- Arrora, S. K., N. Sinha, R. Sinha, R. Bateja, S. Sharma, and R. S. Upadhayaya. 2004. Design, synthesis, modelling and activity of novel anti tubercular compounds, abstr. 63. Abstr. Am. Chem. Soc. Meet.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
